Observational studyAdvances in therapy2024

Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study.

Michael Lehrke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.